One Patient Strategy Doesn’t Fit All: Adapting Patient Engagement Across Diseases, Development Stages & Healthcare Systems

• Exploring how patient engagement strategies should evolve across different tumour types, therapeutic modalities and stages of radiopharmaceutical development, recognising that each programme presents unique patient needs and evidence requirements
• Sharing practical examples of how patient insights can strengthen early clinical development, clinical trial design, educational materials and regulatory interactions across diverse oncology indications
• Examining how patient engagement approaches should adapt as programmes progress from first-in-human studies through to late-stage clinical development, commercialisation and broader implementation

Speakers: